Oncology Journal Articles

• ctDNA for Tracking Minimal Residual Disease in Colon Cancer Find out about the potential role of plasma circulating-tumor DNA in determining minimal residual disease in patients with localized colon cancer.
  Annals of Oncology, February 10, 2020
• Distinct Features of Thin Nodular Primary Melanomas What could the clinical and histological characteristics of thin nodular melanomas tell us about patient prognosis?
  Journal of the National Cancer Institute, February 05, 2020
• Consensus on Management of EGFR-Mutant Lung Cancer Consensus-based recommendations from the Society for Translational Medicine addresses the management of EGFR-mutated lung cancer.
  Translational Lung Cancer Research, February 03, 2020
• Oral Vinorelbine With Endocrine Therapy for Breast Cancer Is the combination of oral metronomic vinorelbine plus letrozole safe and effective for ER+ breast cancer?
  Breast Cancer Research, January 28, 2020
• Opioid Prescribing and Potential Harms for Cancer Patients A new analysis provides insight into patterns of opioid prescriptions for cancer pain. Might the availability of these medications contribute to opioid-related harms?
  Journal of Oncology Practice, January 28, 2020
• Breast Cancer Index and Extended Endocrine Therapy Benefit Might the Breast Cancer Index effectively predict benefit from extended endocrine treatment? Data from the aTTom trial provides insight.
  Annals of Oncology, January 27, 2020
• Female Breast Cancer in Asians vs the US Population In what ways might the patterns and pathological features of breast cancer differ between Asian and non-Asian American women?
  Journal of the National Cancer Institute, January 22, 2020
• Impact of Antibiotics on Outcomes in Cancer Patients on IO What impact do antibiotic-related changes of the gut microbiome have on efficacy of immune-checkpoint inhibitors?
  Annals of Oncology, January 20, 2020
• Bridging the Data-Free Zone: Treating Cancer in Older Adults How do you make effective treatment decisions for real-world geriatric cancer patients who don't fit the typical clinical trial mold?
  Journal of Clinical Oncology, January 17, 2020
• Differing Preferences for DNRs Between Patients and Families Are patients whose care preferences differ from that of their families less likely to have a DNR order placed?
  Journal of Oncology Practice, January 14, 2020
• Immunotherapy for CRC: Current and Novel Approaches Review the latest on targeted mAbs, checkpoint inhibitors, adoptive T-cell therapies, and vaccine therapies for colorectal cancer.
  Journal of the National Cancer Institute, January 10, 2020
• T-DM1, Lapatinib, Nab-paclitaxel in HER2+ Breast Cancer Should dual HER2 blockade plus nab-paclitaxel be considered for neoadjuvant treatment of HER2+ breast cancer?
  Breast Cancer Research, January 07, 2020
• Estimating Benefits of Therapy for Early-Stage Breast Cancer Based on the new evidence, which loco-regional and systemic therapies have the most impact on risk of recurrence and overall survival in early breast cancer?
  Annals of Oncology, January 06, 2020
• TP53 Status as Determinant of ESR2 Effects in Breast Cancer Therapeutic modification of the mutant TP53-ESR2 interaction with agents such as tamoxifen may offer promise for triple negative breast cancer.
  Journal of the National Cancer Institute, January 03, 2020
• Is Lowering PD-L1 Threshold for Pembrolizumab a Good Idea? What is the best treatment option for patients with advanced NSCLC and PD-L1 of 1-49% on tumor cells?
  Translational Lung Cancer Research, January 02, 2020
• The Association Between Hysterectomy and Ovarian Cancer Risk Many think that hysterectomy without oophorectomy protects from invasive ovarian cancer. But is that really true?
  Journal of the National Cancer Institute, December 27, 2019
• Zoledronic Acid and Neoadjuvant Chemo in HER2- Breast Cancer While adjuvant bisphosphonates are associated with longer survival in postmenopausal women with breast cancer, the same cannot be said for neoadjuvant bisphosphonates.
  Breast Cancer Research, December 24, 2019
• Methylation-Based Biological Age and Breast Cancer Risk Can alterations in DNA methylation--biological "clocks" correlating with chronological age--predict risk of breast cancer?
  Journal of the National Cancer Institute, December 20, 2019
• Romiplostim for Chemotherapy-Induced Thrombocytopenia Does the thrombopoietin receptor agonist romiplostim expedite correction of thrombocytopenia caused by chemotherapy?
  Journal of Clinical Oncology, December 11, 2019
• The Oncologist as Therapist Without realizing it, oncologists often serve as psychotherapists to their patients. Which psychotherapeutic principles may benefit patient interactions most?
  Journal of Oncology Practice, December 03, 2019